Nanomedicine: Tiny Particles and Machines Give Huge Gains

被引:0
作者
Sheng Tong
Eli J. Fine
Yanni Lin
Thomas J. Cradick
Gang Bao
机构
[1] Georgia Institute of Technology and Emory University,Department of Biomedical Engineering
来源
Annals of Biomedical Engineering | 2014年 / 42卷
关键词
Nanomedicine; Nanoparticles; Molecular imaging probes; Engineered nucleases; Multifunctional nanoparticle; Genome editing;
D O I
暂无
中图分类号
学科分类号
摘要
Nanomedicine is an emerging field that integrates nanotechnology, biomolecular engineering, life sciences and medicine; it is expected to produce major breakthroughs in medical diagnostics and therapeutics. Nano-scale structures and devices are compatible in size with proteins and nucleic acids in living cells. Therefore, the design, characterization and application of nano-scale probes, carriers and machines may provide unprecedented opportunities for achieving a better control of biological processes, and drastic improvements in disease detection, therapy, and prevention. Recent advances in nanomedicine include the development of nanoparticle (NP)-based probes for molecular imaging, nano-carriers for drug/gene delivery, multifunctional NPs for theranostics, and molecular machines for biological and medical studies. This article provides an overview of the nanomedicine field, with an emphasis on NPs for imaging and therapy, as well as engineered nucleases for genome editing. The challenges in translating nanomedicine approaches to clinical applications are discussed.
引用
收藏
页码:243 / 259
页数:16
相关论文
共 458 条
[1]  
Alexiou C(2000)Locoregional cancer treatment with magnetic drug targeting Cancer Res. 60 6641-6648
[2]  
Alivisatos P(2004)The use of nanocrystals in biological detection Nat. Biotechnol. 22 47-52
[3]  
Alivisatos AP(2005)Quantum dots as cellular probes Annu. Rev. Biomed. Eng. 7 55-76
[4]  
Gu W(2013)Multifunctional nanoparticles for drug delivery and molecular imaging Annu. Rev. Biomed. 15 253-282
[5]  
Larabell C(2007)Transient depletion of Ku70 and Xrcc4 by RNAi as a means to manipulate the non-homologous end-joining pathway J. Biotechnol. 128 246-257
[6]  
Bao G.(1998)FokI dimerization is required for DNA cleavage Proc. Natl. Acad. Sci. USA 95 10570-10575
[7]  
Mitragotri S.(1998)Use of intravascular contrast agents in MRI Acad. Radiol. 5 S223-S225
[8]  
Tong S.(2009)Breaking the code of DNA binding specificity of TAL-type III effectors Science 326 1509-1512
[9]  
Bertolini LR(2005)Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin Microbiology 151 2551-2561
[10]  
Bitinaite J(2007)Specific and covalent labeling of a membrane protein with organic fluorochromes and quantum dots Proc. Natl. Acad. Sci. USA 104 14753-14758